MarketCap
Facebook
X
TelegramAnnual report 2024
added 11-22-2025
Smith & Nephew plc Market Cap 2011-2025 | SNN
As of December 05, 2025 Smith & Nephew plc has a market cap of $ 23.8 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Smith & Nephew plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 29.7 B | 18.1 B | 20.1 B | 15.7 B | 14.8 B | 13.5 B | 15 B | 16 B | 13.2 B | 10.4 B | 8.61 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 29.7 B | 8.61 B | 15.9 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
16.2 M | - | - | $ 17.2 B |  USA |
 |
AdaptHealth Corp.
AHCO
|
1.43 B | $ 9.47 | -2.87 % | $ 1.27 B | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
Butterfly Network
BFLY
|
766 M | $ 2.75 | -1.79 % | $ 582 M | USA |
 |
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | USA |
 |
Delcath Systems
DCTH
|
375 M | $ 9.32 | -2.71 % | $ 266 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
Electromed
ELMD
|
175 M | $ 27.6 | 0.66 % | $ 233 M | USA |
 |
Establishment Labs Holdings
ESTA
|
1.2 B | $ 68.04 | 0.37 % | $ 1.92 B |  Costa-rica |
 |
Second Sight Medical Products
EYES
|
225 K | - | -0.97 % | $ 54.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
FONAR Corporation
FONR
|
85.2 M | $ 14.36 | 0.97 % | $ 94.1 M | USA |
 |
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | USA |
 |
Abbott Laboratories
ABT
|
235 B | $ 126.4 | -1.3 % | $ 220 B | USA |
 |
Bruker Corporation
BRKR
|
6.9 K | $ 47.91 | 0.1 % | $ 7.14 K | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Globus Medical
GMED
|
11.4 B | $ 89.76 | -0.09 % | $ 12.2 B | USA |
 |
Boston Scientific Corporation
BSX
|
155 B | $ 99.38 | -1.65 % | $ 146 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Helius Medical Technologies
HSDT
|
3.54 M | $ 4.11 | 9.77 % | $ 2.5 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.88 B | $ 13.33 | 2.05 % | $ 1.03 B | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
Apyx Medical Corporation
APYX
|
45.7 M | $ 4.09 | 1.74 % | $ 142 M | USA |
 |
Accuray Incorporated
ARAY
|
160 M | $ 1.03 | 1.47 % | $ 106 M | USA |
 |
Inogen
INGN
|
195 M | $ 6.77 | -2.66 % | $ 160 M | USA |
 |
IRIDEX Corporation
IRIX
|
48.1 M | $ 0.91 | -2.0 % | $ 14.7 M | USA |
 |
IRadimed Corporation
IRMD
|
670 M | $ 92.81 | 0.54 % | $ 1.18 B | USA |
 |
Integer Holdings Corporation
ITGR
|
4.58 B | $ 70.25 | -2.08 % | $ 2.36 B | USA |
 |
Align Technology
ALGN
|
13.9 B | $ 150.68 | 2.7 % | $ 11.3 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
589 M | $ 17.8 | -0.78 % | $ 411 M | USA |
 |
LivaNova PLC
LIVN
|
2.28 B | $ 63.67 | 0.89 % | $ 3.45 B |  Britain |
 |
Cognyte Software Ltd.
CGNT
|
661 M | $ 8.41 | 3.19 % | $ 604 M |  Israel |
|
LENSAR
LNSR
|
130 M | $ 10.32 | 0.68 % | $ 119 M | USA |
 |
AxoGen
AXGN
|
859 M | $ 27.83 | -2.47 % | $ 1.23 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Pulmonx Corporation
LUNG
|
341 M | $ 1.79 | 1.7 % | $ 70 M | USA |
 |
Alphatec Holdings
ATEC
|
1.55 B | $ 21.42 | -2.46 % | $ 3.06 B | USA |
 |
Medigus Ltd.
MDGS
|
135 M | - | 10.28 % | $ 55.5 M | Israel |
 |
MiMedx Group
MDXG
|
1.18 B | $ 6.73 | 0.9 % | $ 989 M | USA |
 |
ClearPoint Neuro
CLPT
|
466 M | $ 13.46 | -2.07 % | $ 364 M | USA |
 |
CONMED Corporation
CNMD
|
1.94 B | $ 44.44 | -0.16 % | $ 1.37 B | USA |
 |
Myomo
MYO
|
5.64 M | $ 0.89 | -0.46 % | $ 6.28 M | USA |
 |
Inari Medical
NARI
|
3.07 B | - | - | $ 4.23 B | USA |
 |
Aethlon Medical
AEMD
|
3.03 M | $ 4.82 | 14.37 % | $ 7.52 M | USA |
 |
Nemaura Medical
NMRD
|
24.4 M | - | -17.8 % | $ 2.74 M | Britain |